# Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia

> **NCT01557010** · PHASE2 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 140 (actual)

## Conditions studied

- Postherpetic Neuralgia

## Interventions

- **DRUG:** DWP05195
- **DRUG:** DWP05195
- **DRUG:** DWP05195
- **DRUG:** Control

## Key facts

- **NCT ID:** NCT01557010
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2014-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557010, "Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01557010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*